You Position: Home > Paper
Application of glucocorticoids in treatment of COVID-19
( views:701, downloads:162 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Clinical Infectious Diseases
- Issue:
- 1
- DOI:
- 10.3760/cma.j.issn.1674-2397.2021.01.004
- Key Word:
- 新型冠状病毒肺炎;糖皮质激素;细胞因子风暴;Coronavirus disease 2019;Glucocorticoid;Cytokine storm
Abstract： The infection of 2019-nCoV can lead to overexpression of inflammatory factors, triggering cytokine storm and causing serious damage to the body. Glucocorticoids have anti-inflammatory properties and may be an effective treatment option. The use and dosage of glucocorticoids in coronavirus disease 2019 (COVID-19) remains controversial. This article reviews the theoretical basis, clinical evidence, debates and specific measures of glucocorticoids in the treatment of COVID-19, to provide reference for rational application of glucocorticoids in the future.
- [1]徐凯进,蔡洪流,沈毅弘,等.2019冠状病毒病（COVID-19）诊疗浙江经验[J].2020,(2).
- [2]Rhen Turk,Cidlowski John A..Antiinflammatory Action of Glucocorticoids\u2014 New Mechanisms for Old Drugs[J].2005.
- [3]Li Huan,Chen Chongxiang,Hu Fang,etc.Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis[J].2020,34(6).
- [4]Xiaowei Li,Manman Geng,Yizhao Peng,etc.Molecular immune pathogenesis and diagnosis of COVID-19[J].2020,10(2).
- [5]Ding Cheng,Feng Xuewen,Chen Yanfei,etc.Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study[J].2020,9(4).
- [6]Lei,Zha,Shirong,Li,Lingling,Pan,etc.Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19).[J].2020.
- [7].Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial[J].2020,8(3).
- [8]Arabi, Yaseen M.,Mandourah, Yasser,Al-Hameed, Fahad,etc.Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome[J].2018,197(6).
- [9].SARS: systematic review of treatment effects.[J].2006,3(9).
- [10]Jalkanen, Juho,Pettila, Ville,Huttunen, Teppo,etc.Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung[J].2020,46(10).